Navigation Links
NeoClinical Launches Neo PayPerPatient Clinical Trial Recruitment
Date:2/20/2013

Palo Alto, CA/ Sydney, Australia (PRWEB) February 20, 2013

NeoClinical™, the leading digital clinical trial recruitment agency for Australia, New Zealand and Asian markets today officially launched its latest recruitment product, Neo PayPerPatient. Neo PayPerPatient has emerged from 6 months of beta testing, including regulatory compliance, and integration of some of the latest online consumer engagement software and tools.Neo PayPerPatient has already built powerful databases of people wanting more information about the latest clinical trials for conditions including gout, arthritis, Alzheimer’s, menopause, diabetes, prostate cancer and asthma.

Get the PayPerPatient Data Sheet here.

Neo PayPerPatient is a risk share pay-as-you-go solution for new studies or current studies that are under-performing and need a boost to recruitment.Sponsors only pay a nominal fee for partially screened patients then a moderate fee for those that proceed to full enrolment. NeoClinical™ manages all the rest.

NeoClinical™‘s advertising and PR expertise as well as the team’s considerable online and social media experience is already delivering results for clients – saving money and most importantly time. NeoClinical™ study recruitment campaigns feature innovative and EC compliant advertising, public relations and online content marketing campaigns. With more than 80% of internet users seeking health information online and a third of US adults online to look at health information, getting in front of people online is key.

“Dr. Google is where it is all happening, but you need to give people quality informative content that answers their online search,” said co-founder Susan Fitzpatrick-Napier. “NeoClinical™ is a trusted source for original and authentic health news that informs and updates our potential patients.”

NeoClinical™ typically achieves referral conversion rates of 40-60% and recently achieved a 63% conversion rate for a New Zealand Study.

“For too long companies have been spending valuable time and money searching for people. Don’t waste money finding people you don’t need. Just make it easy for people you need to find you,” said Fitzpatrick-Napier.

For more information about the latest research and new clinical trials please visit http://www.NeoClinical.com.

About NeoClinical™ http://www.neoclinical.com
NeoClinical™ is the region's foremost clinical trial marketing agency dedicated to sharing news on the latest clinical research in Australia, New Zealand, and Asia including Korea, Taiwan, Malaysia, India and China.
NeoClinical™ uses the latest population health data and media consumption data to communicate via a sophisticated mix of public relations, advertising and online content marketing. This is combined with the highest level of reporting, measurement and analytics.
NeoClinical™ is headed by award-winning communications executives who have managed global campaigns for some of the world’s leading consumer and healthcare companies.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10440216.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
4. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
5. Neogen Launches Fully Quantitative Lateral Flow Test for DON
6. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
7. iHealth Lab Launches Personalized Web Portal to Store Your Vitals
8. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
9. Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
10. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
11. ERT Launches New Website to Support Significant Commercial Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... regeneration from small lab samples to full-size tissues, bones, even whole organs to ... vascular system that delivers blood deep into the developing tissue. , Current ...
(Date:3/22/2017)... , March 22, 2017 Good Start Genetics, ... has eclipsed the 130 million covered lives mark through ... of Texas . With newly signed ... continues to enjoy strong payor acceptance based on the ... programs and genetic counseling, its industry-leading customer care and ...
(Date:3/22/2017)... York , March 22, 2017 ... largely fragmented, states a research report by Transparency Market ... Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted for ... 2015. The prominent players in this market are focusing ... their product portfolio, which is likely to lead to ...
Breaking Biology Technology:
(Date:3/7/2017)... 7, 2017 Brandwatch , the leading social intelligence ... Prince,s Trust to uncover insights to support its reporting, help ... The UK,s leading youth charity will be using Brandwatch Analytics ... get a better understanding of the topics and issues that are ... ...
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
(Date:3/2/2017)... , March 2, 2017 Australian stem ... (ASX: CYP), has signed an agreement with the ... the Monash Biomedicine Discovery Institute and Department of Pharmacology ... conduct a further preclinical study to support the use ... of asthma.  Asthma is a chronic, ...
Breaking Biology News(10 mins):